RedHill Biopharma Reports 2017 Second Quarter Financial Results

RedHill maintains a debt-free balance sheet with $51 million cash1 at the end of the second quarter of 2017  Select recent milestones include: Initial net revenues of approximately $0.5 million between June 12-30 following commencement of promotional activities in the U.S. by RedHill’s GI-focused sales force with two GI specialty products, Donnatal® and EnteraGam® Positive top-line […]

Nasdaq to Acquire Sybenetix

The acquisition of Sybenetix will further expand Nasdaq’s leadership in the surveillance space and make it a leading provider to the buy-side industry NEW YORK & LONDON, July 25, 2017 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq:NDAQ) today announced that it has entered into a definitive agreement to acquire Sybenetix, a leading surveillance provider that combines behavioral […]

Credit Suisse, Morgan Stanley, and UBS Take Home Top Honors in Institutional Investor’s Inaugural 2017 All-Asia Trading Team Ranking

NEW YORK, July 24, 2017 (GLOBE NEWSWIRE) — Today Institutional Investor launches its All-Asia Trading Team rankings, spotlighting the top electronic, high-touch, and portfolio trading teams along with the best firms providing local market color to the buy-side. More than 14,500 votes were cast by some of the most influential institutional investors. Credit Suisse was […]